Literature DB >> 33211582

Optimal Allocation of Societal HIV Prevention Resources to Reduce HIV Incidence in the United States.

Stephanie L Sansom1, Katherine A Hicks1, Justin Carrico1, Evin U Jacobson1, Ram K Shrestha1, Timothy A Green1, David W Purcell1.   

Abstract

Objectives. To optimize combined public and private spending on HIV prevention to achieve maximum reductions in incidence.Methods. We used a national HIV model to estimate new infections from 2018 to 2027 in the United States. We estimated current spending on HIV screening, interventions that move persons with diagnosed HIV along the HIV care continuum, pre-exposure prophylaxis, and syringe services programs. We compared the current funding allocation with 2 optimal scenarios: (1) a limited-reach scenario with expanded efforts to serve eligible persons and (2) an ideal, unlimited-reach scenario in which all eligible persons could be served.Results. A continuation of the current allocation projects 331 000 new HIV cases over the next 10 years. The limited-reach scenario reduces that number by 69%, and the unlimited reach scenario by 94%. The most efficient funding allocations resulted in prompt diagnosis and sustained viral suppression through improved screening of high-risk persons and treatment adherence support for those infected.Conclusions. Optimal allocations of public and private funds for HIV prevention can achieve substantial reductions in new infections. Achieving reductions of more than 90% under current funding will require that virtually all infected receive sustained treatment.

Entities:  

Mesh:

Year:  2020        PMID: 33211582      PMCID: PMC7750609          DOI: 10.2105/AJPH.2020.305965

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  20 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

2.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

3.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

4.  Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care.

Authors:  Paul G Farnham; Chaitra Gopalappa; Stephanie L Sansom; Angela B Hutchinson; John T Brooks; Paul J Weidle; Vincent C Marconi; David Rimland
Journal:  J Acquir Immune Defic Syndr       Date:  2013-10-01       Impact factor: 3.731

5.  Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment.

Authors:  Trang Quynh Nguyen; Brian W Weir; Don C Des Jarlais; Steven D Pinkerton; David R Holtgrave
Journal:  AIDS Behav       Date:  2014-11

6.  Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.

Authors:  Kamal Desai; Stephanie L Sansom; Marta L Ackers; Scott R Stewart; H Irene Hall; Dale J Hu; Rachel Sanders; Carol R Scotton; Sada Soorapanth; Marie-Claude Boily; Geoffrey P Garnett; Peter D McElroy
Journal:  AIDS       Date:  2008-09-12       Impact factor: 4.177

7.  Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.

Authors:  Alison J Rodger; Valentina Cambiano; Tina Bruun; Pietro Vernazza; Simon Collins; Jan van Lunzen; Giulio Maria Corbelli; Vicente Estrada; Anna Maria Geretti; Apostolos Beloukas; David Asboe; Pompeyo Viciana; Félix Gutiérrez; Bonaventura Clotet; Christian Pradier; Jan Gerstoft; Rainer Weber; Katarina Westling; Gilles Wandeler; Jan M Prins; Armin Rieger; Marcel Stoeckle; Tim Kümmerle; Teresa Bini; Adriana Ammassari; Richard Gilson; Ivanka Krznaric; Matti Ristola; Robert Zangerle; Pia Handberg; Antonio Antela; Sris Allan; Andrew N Phillips; Jens Lundgren
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

8.  Allocating HIV prevention funds in the United States: recommendations from an optimization model.

Authors:  Arielle Lasry; Stephanie L Sansom; Katherine A Hicks; Vladislav Uzunangelov
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

9.  Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.

Authors: 
Journal:  Lancet HIV       Date:  2017-05-10       Impact factor: 12.767

10.  Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.

Authors:  Alison J Rodger; Valentina Cambiano; Tina Bruun; Pietro Vernazza; Simon Collins; Olaf Degen; Giulio Maria Corbelli; Vicente Estrada; Anna Maria Geretti; Apostolos Beloukas; Dorthe Raben; Pep Coll; Andrea Antinori; Nneka Nwokolo; Armin Rieger; Jan M Prins; Anders Blaxhult; Rainer Weber; Arne Van Eeden; Norbert H Brockmeyer; Amanda Clarke; Jorge Del Romero Guerrero; Francois Raffi; Johannes R Bogner; Gilles Wandeler; Jan Gerstoft; Felix Gutiérrez; Kees Brinkman; Maria Kitchen; Lars Ostergaard; Agathe Leon; Matti Ristola; Heiko Jessen; Hans-Jürgen Stellbrink; Andrew N Phillips; Jens Lundgren
Journal:  Lancet       Date:  2019-05-02       Impact factor: 79.321

View more
  4 in total

1.  Optimizing HIV Prevention Efforts to Achieve EHE Incidence Targets.

Authors:  Evin U Jacobson; Katherine A Hicks; Justin Carrico; David W Purcell; Timothy A Green; Jonathan H Mermin; Paul G Farnham
Journal:  J Acquir Immune Defic Syndr       Date:  2022-04-01       Impact factor: 3.771

2.  Updated Estimates of the Number of Men Who Have Sex With Men (MSM) With Indications for HIV Pre-exposure Prophylaxis.

Authors:  Laurel Bates; Amanda Honeycutt; Sarah Bass; Timothy A Green; Paul G Farnham
Journal:  J Acquir Immune Defic Syndr       Date:  2021-12-01       Impact factor: 3.771

3.  Economic benefits of the United States' AIDS drug assistance Program: A systematic review of cost analyses to guide research and policy priorities.

Authors:  Kathleen A McManus; Andrew Strumpf; Amy Killelea; Tim Horn; Auntré Hamp; Jessica Keim-Malpass
Journal:  Prev Med Rep       Date:  2022-08-29

4.  Social Determinants of Health and Care Outcomes Among People With HIV in the United States.

Authors:  Timothy W Menza; Lindsay K Hixson; Lauren Lipira; Linda Drach
Journal:  Open Forum Infect Dis       Date:  2021-06-22       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.